期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
超声内镜引导下无水乙醇注射法与外科手术法治疗良性胰岛素瘤的对比研究 被引量:3
1
作者 蒋艳娟 覃山羽 +10 位作者 姜海行 覃凤燕 刘芷玲 罗佐杰 秦映芬 周嘉 梁瑜祯 梁敏 梁杏欢 陈俊强 覃新干 《中国内镜杂志》 北大核心 2017年第4期8-13,共6页
目的评估超声内镜(EUS)引导下无水乙醇注射法治疗良性胰岛素瘤的疗效与安全性,并与外科手术治疗法相比较。方法回顾性分析2011年4月-2016年2月在广西医科大学第一附属医院经EUS引导下无水乙醇注射法治疗或外科手术法治疗的38例良性胰岛... 目的评估超声内镜(EUS)引导下无水乙醇注射法治疗良性胰岛素瘤的疗效与安全性,并与外科手术治疗法相比较。方法回顾性分析2011年4月-2016年2月在广西医科大学第一附属医院经EUS引导下无水乙醇注射法治疗或外科手术法治疗的38例良性胰岛素瘤临床资料。结果 97.4%(37/38)的患者有典型的Whipple三联征,82.9%(29/35)患者低血糖发作时胰岛素释放指数(I/G)>0.3。术前B超、CT、磁共振成像(MRI)、正电子发射计算机断层显像(PET/CT)和EUS定位诊断胰岛素瘤阳性率分别为50.0%、67.6%、66.7%、75.0%和89.7%。18例行EUS引导下无水乙醇注射治疗(EUS-FNI组),20例行外科手术治疗(外科手术组),EUS-FNI组术后均无并发症发生,外科手术组中40.0%(8/20)患者出现并发症。与外科手术组相比,EUS-FNI组在手术时间、术中出血、术后并发症、术后住院时间和住院总费用上均明显降低(P<0.05)。所有患者均得到随访,EUS-FNI组最后一次无水乙醇注射治疗后所有患者血糖平稳在正常范围;外科手术组20例患者中,90.0%(18/20)患者术后无低血糖症状再发作,监测血糖在正常范围,10.0%(2/20)患者术后低血糖症状发作较术前减少。结论 EUS引导下无水乙醇注射法治疗良性胰岛素瘤安全、有效。与外科手术法相比,具有微创、经济、并发症少和术后恢复快等优势。 展开更多
关键词 胰岛素瘤 超声内镜 细针穿刺 乙醇注射 外科手术
下载PDF
LRP6 Bidirectionally Regulates Insulin Sensitivity through Insulin Receptor and S6K Signaling in Rats with CG-IUGR
2
作者 Xue-mei XIE Qiu-li CAO +10 位作者 Yu-jie SUN Jie ZHANG Kai-li LIU ying-fen qin Wen-jun LONG Zuo-jie LUO Xiao-wei LI Xing-huan LIANG Guan-dou YUAN Xiao-ping LUO Xiu-ping XUAN 《Current Medical Science》 SCIE CAS 2023年第2期274-283,共10页
Objective Intrauterine growth restriction followed by postnatal catch-up growth(CG-IUGR)increases the risk of insulin resistance-related diseases.Low-density lipoprotein receptor-related protein 6(LRP6)plays a substan... Objective Intrauterine growth restriction followed by postnatal catch-up growth(CG-IUGR)increases the risk of insulin resistance-related diseases.Low-density lipoprotein receptor-related protein 6(LRP6)plays a substantial role in glucose metabolism.However,whether LRP6 is involved in the insulin resistance of CG-IUGR is unclear.This study aimed to explore the role of LRP6 in insulin signaling in response to CG-IUGR.Methods The CG-IUGR rat model was established via a maternal gestational nutritional restriction followed by postnatal litter size reduction.The mRNA and protein expression of the components in the insulin pathway,LRP6/β-catenin and mammalian target of rapamycin(mTOR)/S6 kinase(S6K)signaling,was determined.Liver tissues were immunostained for the expression of LRP6 andβ-catenin.LRP6 was overexpressed or silenced in primary hepatocytes to explore its role in insulin signaling.Results Compared with the control rats,CG-IUGR rats showed higher homeostasis model assessment for insulin resistance(HOMA-IR)index and fasting insulin level,decreased insulin signaling,reduced mTOR/S6K/insulin receptor substrate-1(IRS-1)serine307 activity,and decreased LRP6/β-catenin in the liver tissue.The knockdown of LRP6 in hepatocytes from appropriate-for-gestational-age(AGA)rats led to reductions in insulin receptor(IR)signaling and mTOR/S6K/IRS-1 serine307 activity.In contrast,LRP6 overexpression in hepatocytes of CG-IUGR rats resulted in elevated IR signaling and mTOR/S6K/IRS-1 serine307 activity.Conclusion LRP6 regulated the insulin signaling in the CG-IUGR rats via two distinct pathways,IR and mTOR-S6K signaling.LRP6 may be a potential therapeutic target for insulin resistance in CG-IUGR individuals. 展开更多
关键词 intrauterine growth restriction followed by postnatal catch-up growth insulin signaling lipoprotein receptor-related protein 6 Wnt signaling mammalian target of rapamycin/S6 kinase signaling
下载PDF
Use of First-phase Insulin Secretion in Early Diagnosis of Thyroid Diabetes and Type 2 Diabetes Mellitus 被引量:13
3
作者 Li-Heng Meng Yao Huang +4 位作者 Jia Zhou Xing-Huan Liang Jing Xian Li Li ying-fen qin 《Chinese Medical Journal》 SCIE CAS CSCD 2017年第7期798-804,共7页
Background:A relationship between hyperthyroidism and insulin secretion in type 2 diabetes mellitus (T2DM) has been reported.Therefore,this study explored the use of first-phase insulin secretion in the differentia... Background:A relationship between hyperthyroidism and insulin secretion in type 2 diabetes mellitus (T2DM) has been reported.Therefore,this study explored the use of first-phase insulin secretion in the differential diagnosis of thyroid diabetes (TDM) and T2DM.Methods:In total,101 patients with hyperthyroidism were divided into hyperthyroidism with normal glucose tolerance (TNGT),hyperthyroidism with impaired glucose regulation (TIGR),and diabetes (TDM) groups.Furthermore,96 patients without hyperthyroidism were recruited as control groups (normal glucose tolerance [NGT],impaired glucose regulation [IGR],and T2DM).The following parameters were evaluated:homeostasis model assessment (HOMA)-IR,HOMA-β,modified β-cell function index (MBCI),peak insulin/fasting insulin (IP/I0),AUCins-OGTT,and AUCins-OGTr/AUCglu-OGTT from the oral glucose tolerance test (OGTT) insulin release test were utilized to assess the second-phase insulin secretion,while the IP/I0,AIR0'-10',and AUCins-IVGTT from the intravenous glucose tolerance test (IVGTT) insulin release test were used to assess the first-phase insulin secretion.Results:In the OGTT,the HOMA-β values of the TNGT and TDM groups were higher than those of the NGT and T2DM groups (all P 〈 0.05).In the hyperthyroidism groups,the MBCI of the TDM group was lower than that of the TNGT and TIGR groups (all P 〈 0.05).Among the control groups,the MBCI values of the IGR and T2DM groups were lower than that of the normal glucose tolerance (NGT) group (all P 〈 0.05).In the IVGTT,insulin secretion peaked for all groups at 2-4 min,except for the T2DM group,which showed a low plateau and no secretion peak.The IPvalues of the TNGT,TIGR,and TDM groups were higher than those of the NGT,IGR,and T2DM groups (all P 〈 0.05).The IP/I0,AIR0'-10',and AUCins-IVGTT values of the TDM group were higher than those of the T2DM group but were lower than those of the TNGT,TIGR,NGR,and IGR groups (all P 〈 0.05).Compared with the other five groups,the IP/I0 AIR0'-10',and AUCins-IVGTT values of the T2DM group were significantly decreased (all P 〈 0.05).The IP/I0 and AUCins-IVGTT values of the TNGT group were higher than those of the NGT group (all P 〈 0.05).Conclusions:β-cell function in TDM patients is superior to that in T2DM patients.First-phase insulin secretion could be used as an early diagnostic marker to differentiate TDM and T2DM. 展开更多
关键词 Diabetes Mellitus First-phase Insulin Secretion: Intravenous Glucose: Oral Glucose: Thyroid Diabetes
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部